Mufg Americas Holdings Corp Biomarin Pharmaceutical Inc Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	SELL	$82.16 - $96.94 $26,126 - $30,826	-318 Reduced 3.24%	9,486 $805,000
Q3 2022 Oct 31, 2022	SELL	$82.16 - $96.94 $26,126 - $30,826	-318 Reduced 3.24%	9,486 $805,000
Q2 2022 Dec 01, 2022	SELL	$71.48 - $86.85 $26,018 - $31,613	-364 Reduced 3.58%	9,804 $812,000
Q2 2022 Aug 02, 2022	SELL	$71.48 - $86.85 $26,018 - $31,613	-364 Reduced 3.58%	9,804 $812,000
Q1 2022 Dec 01, 2022	BUY	$74.28 - $92.69 $19,164 - $23,914	258 Added 2.6%	10,168 $783,000
Q1 2022 May 06, 2022	BUY	$74.28 - $92.69 $19,164 - $23,914	258 Added 2.6%	10,168 $783,000
Q4 2021 Dec 01, 2022	SELL	$71.72 - $91.47 $526,137 - $671,023	-7,336 Reduced 42.54%	9,910 $875,000
Q4 2021 Feb 09, 2022	SELL	$71.72 - $91.47 $526,137 - $671,023	-7,336 Reduced 42.54%	9,910 $875,000
Q3 2021 Dec 01, 2022	SELL	$74.77 - $85.47 $65,797 - $75,213	-880 Reduced 4.85%	17,246 $1.33 Million
Q3 2021 Nov 05, 2021	SELL	$74.77 - $85.47 $65,797 - $75,213	-880 Reduced 4.85%	17,246 $1.33 Million
Q2 2021 Dec 01, 2022	BUY	$75.51 - $84.79 $133,803 - $150,247	1,772 Added 10.84%	18,126 $1.51 Million
Q2 2021 Aug 06, 2021	BUY	$75.51 - $84.79 $133,803 - $150,247	1,772 Added 10.84%	18,126 $1.51 Million
Q1 2021 Dec 01, 2022	BUY	$74.73 - $90.69 $513,768 - $623,493	6,875 Added 72.53%	16,354 $1.24 Million
Q1 2021 Apr 30, 2021	BUY	$74.73 - $90.69 $513,768 - $623,493	6,875 Added 72.53%	16,354 $1.24 Million
Q4 2020 Dec 01, 2022	BUY	$72.61 - $90.2 $152,771 - $189,780	2,104 Added 28.53%	9,479 $831,000
Q4 2020 Feb 03, 2021	BUY	$72.61 - $90.2 $152,771 - $189,780	2,104 Added 28.53%	9,479 $831,000
Q3 2020 Dec 01, 2022	SELL	$71.87 - $131.03 $140,074 - $255,377	-1,949 Reduced 20.9%	7,375 $561,000
Q3 2020 Nov 03, 2020	SELL	$71.87 - $131.03 $140,074 - $255,377	-1,949 Reduced 20.9%	7,375 $561,000
Q2 2020 Dec 01, 2022	SELL	$79.55 - $124.22 $12,887 - $20,123	-162 Reduced 1.71%	9,324 $1.15 Million
Q2 2020 Aug 06, 2020	BUY	$79.55 - $124.22 $104,130 - $162,603	1,309 Added 16.33%	9,324 $1.15 Million
Q1 2020 Apr 24, 2020	BUY	$71.37 - $96.85 $118,616 - $160,964	1,662 Added 26.16%	8,015 $677,000
Q4 2019 Feb 10, 2020	BUY	$64.27 - $86.37 $316,979 - $425,976	4,932 Added 347.08%	6,353 $537,000
Q3 2019 Nov 06, 2019	BUY	$67.4 - $85.11 $81,891 - $103,408	1,215 Added 589.81%	1,421 $96,000
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $16,552 - $19,343	206 New	206 $18,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account